Silas Holland | Director of Infectious Disease Policy
Merck & Co

Silas Holland, Director of Infectious Disease Policy, Merck & Co

Silas Holland is a Director for Global Public Policy at Merck, where he is responsible for global health policy issues in infectious disease, primarily focusing on antibiotics/antifungals.
Over the past 15 years, he has worked on programs at both the community- and global-level to expand access to medicines. He joined Merck from the Global Fund to Fight AIDS, Tuberculosis, and Malaria, where he was responsible for the sourcing of tuberculosis health products. He has also worked for the World Health Organization and Stop TB Partnership.
 He earned a BA in Biology from Duke University and has postgraduate degrees in education (Loyola Marymount University) and public health (University of Pretoria).
 

Appearances:



World Anti-Microbial Resistance Congress USA 2018 - Day 1 @ 09:20

Keynote address: Coordinated Pull – engaging all stakeholders to make “pull” incentives a reality

  • How can industry, regulators and funders come together to implement effective pull incentives
  • Using evidence provided buy studies like the DRIVE AB report to influence policy makers
  • Looking at different funding models with continuous clinical evaluation
  • Picking the baton from push initiatives to achieve viable commercial feasibility
  • Analyzing market entry rewards, transferable vouchers, and FDA proposed licensing model
last published: 16/Oct/18 20:05 GMT

back to speakers